Regulation - Pixuvri


Current filters:


Popular Filters

Cell Thera’s NHL drug Pixuvri gets backing from UK’s NICE


US biotech firm Cell Therapeutics has received positive news from the UK’s drugs watchdog for use of…

BiotechnologyCell TherapeuticsNorthern EuropeOncologyPixuvriPricingRegulationUK

UK’s NICE says yes to Cell Thera’s non-Hodgkin’s lymphoma drug Pixuvri

UK’s NICE says yes to Cell Thera’s non-Hodgkin’s lymphoma drug Pixuvri


US biotech firm Cell Therapeutics’ Pixuvri (pixantrone), a treatment for an aggressive type of cancer…

BiotechnologyCell TherapeuticsEuropeOncologyPixuvriPricingRegulation

UK’s NICE reconsiders backing for lymphoma drug Pixuvri


The UK's National Institute for Health and Care Excellence has launched a second consultation on draft…

Cell TherapeuticsEuropeOncologyPharmaceuticalPixuvriPricingRegulation

Non-Hodgkin lymphoma treatment Pixuvri given market access in France


USA-based Cell Therapeutics (Nasdaq: CTIC) has been granted market access in France for its aggressive…

Cell TherapeuticsEuropeOncologyPharmaceuticalPixuvriRegulation

Germany's G-BA issues final assessment for Cell Thera's Pixuvri


USA-based Cell Therapeutics (Nasdaq: CTIC) says that Germany's Federal Joint Committee (G-BA) has issued…

BiotechnologyCell TherapeuticsEuropeOncologyPharmaceuticalPixuvriPricingRegulation

Cell Therapeutics' Pixuvri cleared in EU for NHL


US biotech firm Cell Therapeutics (Nasdaq and MTA: CTIC) last week received conditional marketing authorization…

BiotechnologyCell TherapeuticsEuropeOncologyPharmaceuticalPixuvriRegulation

Cell Therapeutics updates on Pixuvri


Seattle, USA-based Cell Therapeutics (Nasdaq and MTA: CTIC) says that it has voluntarily withdrawn its…

BiotechnologyCell TherapeuticsNorth AmericaOncologyPixuvriRegulation

FDA advisory to review Cell Thera’s re-submitted pixantrone NDA


The US Food and Drug Administration's Oncologic Drugs Advisory Committee (ODAC) will review Cell Therapeutics’…

Cell TherapeuticsNorth AmericaOncologyPharmaceuticalpixantronePixuvriRegulation

Back to top